If you’ve been wondering why the PCC distinguishes between ‘pre-apps’ and ‘full apps’,  it’s because these unique applications have very different goals – and time commitments – associated with them.

The PCC pre-application is due on March 1st, July 1st,and November 1st of each year. It is designed to ensure a proposed project will meet basic funding requirements, such as alignment with the PCC’s research priorities and mission. This step also provides basic information related to the applicant’s research objective and scientific approach.

All pre-applications are evaluated by the PCC’s Scientific Advisory Board Chair. If the project proposal showcases potential as a good contender for PCC funding, the pre-app will be approved, and the investigator may begin the full application, due April 1st, August 1st, or December 1st, depending on the cycle.

The pre-application process ensures that investigators do not spend unnecessary time completing the PCC’s time-intensive full application if their project will not be a good fit for PCC funding (for example, if the project does not align with PCC research priorities).

The pre-app addresses the following research related questions:

Basic Information
Project Title:
Direct Costs of Research:
Indirect Costs of Research:
Months to Complete:

Research Particulars
Research Objective:
How will this project contribute to the PCC Mission?
Project Summary (maximum 200 words)
Scientific Project Proposal Abstract (including the approach that will be undertaken) (maximum 500 words)

Alignment with PCC Research Priorities
Please check all PCC priorities addressed by the research to be conducted:

Developing methods of cost-effective testing to detect and deter the use of banned and illegal substances.

Developing testing protocols to detect designer substances used for doping purposes.

Improving existing analytical methods to detect particular drugs, ex. GH, IGF-1, EPO, hCG.

Developing analytical methods to detect performance enhancing drugs not currently detectable.

Longitudinal urinary excretion patterns, metabolism and dose-concentration.

Critical reviews to support interpretation of laboratory data.

Alternative specimens, (ex. hair, sweat, saliva, interstitial fluid) for testing.


The PCC encourages investigators to submit a pre-application before the next deadline.